(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane

C105H113N31O24 — CID 157238826

IUPAC(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane
SMILESC.COc1ccc(CO[C@@H]2[C@H](C)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(N)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChIInChI=1S/C26H26N8O4.C25H24N8O5.C25H25N5O6.C18H21N5O5.C10H13N5O4.CH4/c1-16-20(12-31-33-27)38-26(22(16)37-13-17-8-10-19(36-2)11-9-17)34-15-30-21-23(28-14-29-24(21)34)32-25(35)18-6-4-3-5-7-18;1-36-17-9-7-15(8-10-17)12-37-21-20(34)18(11-30-32-26)38-25(21)33-14-29-19-22(27-13-28-23(19)33)31-24(35)16-5-3-2-4-6-16;1-34-17-9-7-15(8-10-17)12-35-21-20(32)18(11-31)36-25(21)30-14-28-19-22(26-13-27-23(19)30)29-24(33)16-5-3-2-4-6-16;1-26-11-4-2-10(3-5-11)7-27-15-14(25)12(6-24)28-18(15)23-9-22-13-16(19)20-8-21-17(13)23;11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h3-11,14-16,20,22,26H,12-13H2,1-2H3,(H,28,29,32,35);2-10,13-14,18,20-21,25,34H,11-12H2,1H3,(H,27,28,31,35);2-10,13-14,18,20-21,25,31-32H,11-12H2,1H3,(H,26,27,29,33);2-5,8-9,12,14-15,18,24-25H,6-7H2,1H3,(H2,19,20,21);2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H4/t16-,20-,22-,26-;2*18-,20-,21-,25-;12-,14-,15-,18-;4-,6-,7-,10-;/m11111./s1
InChIKeyAUYRWKVOULPFDP-SYBWBQCDSA-N
MW2193.25 g/mol
LogP8.59
Rot. Bonds34

About (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane

(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane (PubChem CID 157238826) has the molecular formula C105H113N31O24 and a molecular weight of 2193.25 g/mol. Its IUPAC name is (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane.

Molecular Properties

Compound Name(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane
PubChem CID157238826
Molecular FormulaC105H113N31O24
Molecular Weight2193.25 g/mol
Exact Mass2191.86
IUPAC Name(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane
SMILESC.COc1ccc(CO[C@@H]2[C@H](C)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(N)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
InChIInChI=1S/C26H26N8O4.C25H24N8O5.C25H25N5O6.C18H21N5O5.C10H13N5O4.CH4/c1-16-20(12-31-33-27)38-26(22(16)37-13-17-8-10-19(36-2)11-9-17)34-15-30-21-23(28-14-29-24(21)34)32-25(35)18-6-4-3-5-7-18;1-36-17-9-7-15(8-10-17)12-37-21-20(34)18(11-30-32-26)38-25(21)33-14-29-19-22(27-13-28-23(19)33)31-24(35)16-5-3-2-4-6-16;1-34-17-9-7-15(8-10-17)12-35-21-20(32)18(11-31)36-25(21)30-14-28-19-22(26-13-27-23(19)30)29-24(33)16-5-3-2-4-6-16;1-26-11-4-2-10(3-5-11)7-27-15-14(25)12(6-24)28-18(15)23-9-22-13-16(19)20-8-21-17(13)23;11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h3-11,14-16,20,22,26H,12-13H2,1-2H3,(H,28,29,32,35);2-10,13-14,18,20-21,25,34H,11-12H2,1H3,(H,27,28,31,35);2-10,13-14,18,20-21,25,31-32H,11-12H2,1H3,(H,26,27,29,33);2-5,8-9,12,14-15,18,24-25H,6-7H2,1H3,(H2,19,20,21);2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H4/t16-,20-,22-,26-;2*18-,20-,21-,25-;12-,14-,15-,18-;4-,6-,7-,10-;/m11111./s1
InChIKeyAUYRWKVOULPFDP-SYBWBQCDSA-N
XLogP8.59
TPSA736.69 Ų
H-Bond Donors13
H-Bond Acceptors48
Rotatable Bonds34
Heavy Atoms160
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002193.25
LogP ≤ 58.59
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1048

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'azo_A(324)', 'substructure': 'N/A'}, {'alert_name': 'Azido_group', 'substructure': 'N/A'}, {'alert_name': 'diazo_group', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_3', 'substructure': 'N/A'}

Analyze (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Adenosine, N-benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxy-
CID 2724489
N-(9-((2R,3R,4S,5R)-4-(Tert-butyldimethylsilyloxy)-3-hydroxy-5-(((4-meth oxyphenyl)diphenylmethoxy)methyl)tetrahydrofuran-2-YL)-9H-purin-6-YL)ben zamide
CID 13941005
Dimethoxytrityl-a-d[GGG]-ap-dG-3'
CID 16134255
n6-benzoyl-5'-o-(4,4-dimethoxytrityl)-2'-deoxyadenosine-3'-succinate, tea salt
CID 138375999
N-benzoyl-2'-O-[n2,n6-bis(trifluoroacetyl)lysyl]aminohexyl-5'-O-(4,4'-dimethoxytrityl)adenosine
CID 129840965
n6-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-dmt-adenosine
CID 13871228
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)(phenyl)methyl)-2'-O-(tert-butyl(dimethyl)silyl)adenosine
CID 13871229
5'-(4,4'-dimethoxytrityl)-N-benzoyl-2'-deoxyadenosine
CID 18646768
N-Benzoyl-5'-O-(bis(4-methoxyphenyl)phenylmethyl)-2'-deoxyadenosine 3'-O-succinate
CID 11018132
DMT-2'-F-Bz-dA
CID 11125261
N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-fluoro-3-hydroxyoxolan-2-yl]purin-6-yl]benzamide
CID 15216900
N-[9-[(2R,3S,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3-fluoro-3,4-dihydroxyoxolan-2-yl]purin-6-yl]benzamide
CID 56977467

Frequently Asked Questions

What is the IUPAC name of (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane?
The IUPAC name of (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane (CID 157238826) is (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane.
What is the SMILES notation for (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane?
The canonical SMILES for (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane is C.COc1ccc(CO[C@@H]2[C@H](C)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CN=[N+]=[N-])O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(N)ncnc32)cc1.COc1ccc(CO[C@@H]2[C@H](O)[C@@H](CO)O[C@H]2n2cnc3c(NC(=O)c4ccccc4)ncnc32)cc1.Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O.
What is the InChIKey of (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane?
The InChIKey is AUYRWKVOULPFDP-SYBWBQCDSA-N. The full InChI is InChI=1S/C26H26N8O4.C25H24N8O5.C25H25N5O6.C18H21N5O5.C10H13N5O4.CH4/c1-16-20(12-31-33-27)38-26(22(16)37-13-17-8-10-19(36-2)11-9-17)34-15-30-21-23(28-14-29-24(21)34)32-25(35)18-6-4-3-5-7-18;1-36-17-9-7-15(8-10-17)12-37-21-20(34)18(11-30-32-26)38-25(21)33-14-29-19-22(27-13-28-23(19)33)31-24(35)16-5-3-2-4-6-16;1-34-17-9-7-15(8-10-17)12-35-21-20(32)18(11-31)36-25(21)30-14-28-19-22(26-13-27-23(19)30)29-24(33)16-5-3-2-4-6-16;1-26-11-4-2-10(3-5-11)7-27-15-14(25)12(6-24)28-18(15)23-9-22-13-16(19)20-8-21-17(13)23;11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10;/h3-11,14-16,20,22,26H,12-13H2,1-2H3,(H,28,29,32,35);2-10,13-14,18,20-21,25,34H,11-12H2,1H3,(H,27,28,31,35);2-10,13-14,18,20-21,25,31-32H,11-12H2,1H3,(H,26,27,29,33);2-5,8-9,12,14-15,18,24-25H,6-7H2,1H3,(H2,19,20,21);2-4,6-7,10,16-18H,1H2,(H2,11,12,13);1H4/t16-,20-,22-,26-;2*18-,20-,21-,25-;12-,14-,15-,18-;4-,6-,7-,10-;/m11111./s1.
What are the key properties of (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane?
(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane has a molecular weight of 2193.25 g/mol, XLogP of 8.59, 34 rotatable bonds, 13 hydrogen bond donors, and 48 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-[(4-methoxyphenyl)methoxy]oxolan-3-ol;(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol;N-[9-[(2R,3R,4R,5R)-5-(azidomethyl)-4-hydroxy-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5S)-5-(azidomethyl)-3-[(4-methoxyphenyl)methoxy]-4-methyloxolan-2-yl]purin-6-yl]benzamide;N-[9-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-[(4-methoxyphenyl)methoxy]oxolan-2-yl]purin-6-yl]benzamide;methane is sourced from PubChem (CID 157238826), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).